CXCL9 and Parkinson disease: Inconsistent with the results of previous studies, our findings suggest that PD leads to reduced levels of inflammatory factors such as MIG, bNGF, IL-17, IL-2, and IFNg through pathological pathways, which may be attributed to the fact that the levels of inflammatory markers are influenced by the course, extent, and duration of PD.